HIV Mutation Detail Information

> I85V Search Result


Mutation Information
Mutation Site I85V
Mutation Type Amino acid level
Gene/Protein/Region Type PR
Relevant Drug PIs
Country Uganda
Literature Information
PubMed PMID 32025714
Disease HIV infection/AIDS
Published Year 2020
Journal The Journal of antimicrobial chemotherapy
Title Prevalence of viral load suppression, predictors of virological failure and patterns of HIV drug resistance after 12 and 48 months on first-line antiretroviral therapy: a national cross-sectional survey in Uganda.
Author Ssemwanga D,Asio J,Watera C,Nannyonjo M,Nassolo F,Lunkuse S,Salazar-Gonzalez JF,Salazar MG,Sanyu G,Lutalo T,Kabuga U,Ssewanyana I,Namatovu F,Namayanja G,Namale A,Raizes E,Kaggwa M,Namuwenge N,Kirungi W,Katongole-Mbidde E,Kaleebu P,Uganda HIV Drug Resistance Technical Working Group.
Evidence One patient (1.1%;95% CI 0.14%-3.6%) had the I85V PI mutation, 23 (90.3%;95% CI 65.6%-97.9%) had NRTI mutations, 26 (94.1%;95% CI 74.3%-98.9%) had NNRTI mutations and 22 (89.5%;95% CI 64.7%-97.5%) had both NRTI and NNRTI mutations (Table 2).

Contents
Description
Mutation Information Note
  • Gene/Protein/Region Type: Virus Gene (e.g. LMP-1) or Virus Protein (e.g. Rep 68) or Virus Region (e.g. S, X)
Literature Information Note
  • Evidence: sentence contains this mutation information in the citation